News

Article

AJMC® in the Press, January 26, 2024

Author(s):

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article from mHealthIntelligence referenced a study published in the January 2024 issue of The American Journal of Managed Care® (AJMC®). The study, “Characterizing Telehealth Use in the US: Analysis of the 2022 Health Information National Trends Survey,” concluded that discussing the motivation of patients to use telehealth could help policy makers and administrators to maximize health care access and quality.

An article from Good Men Project referenced an article published in the April 2021 issue of AJMC. The piece, “Enhance Care Continuity Post COVID-19,” argued that the pandemic had created an opportunity to augment continuity to improve patient-centered outcomes and improve spending efficiency.

An article from Biospace referenced an article published on AJMC.com, the website of AJMC. The article, “Analysis Explores Gene Therapy’s Potential to Be Cost-Effective in SCD,” reported gene therapy in the treatment of sickle cell disease could be cost effective if it was priced below the $2 million mark.

Related Videos
Kimberly Westrich, MA, chief strategy officer, NPC
Image credit: Medical technology and futuristic concept. Doctor hologram modern virtual screen interface | SOMKID - stock.adobe.com
Erin Weber, MS
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Marla Black Morgan, MD, Phoebe Neurology Associates
Elizabeth Grush, MBA
Raj Chovatiya, MD, PhD, MSCI.
1 expert in this video
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo